EXACT Sciences Corporation Stock News

Has this been a market-beating investment?

Smart Beta ETF report for FBT

In the latest trading session, Exact Sciences (EXAS) closed at $64.36, marking a -0.16% move from the previous day.

Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-mark

In the latest trading session, Exact Sciences (EXAS) closed at $64.46, marking a +1.45% move from the previous day.

It pays to be an innovator.

Moderna is helping move the vaccine industry forward with its mRNA approach. Exact Sciences' products help patients and physicians better fight against cancer.

Upgrades For HNI Corp (NYSE:HNI), Sidoti & Co. upgraded the previous rating of Neutral to Buy. For the fourth quarter, HNI had an EPS of $0.63, compared to year-ago quarter EPS of $0.43. At the moment

Exact Sciences (EXAS) closed at $66.08 in the latest trading session, marking a -1.42% move from the prior day.

About 20,000 new cases of colorectal cancer are expected to be diagnosed in people younger than 50 this year, according to the American Cancer Society.

Exact Sciences is shifting its focus towards achieving positive adjusted EBITDA as a way to signal a path to eliminate cash burn. Here's my take on EXAS stock.

Exact Sciences is shifting its focus towards achieving positive adjusted EBITDA as a way to signal a path to eliminate cash burn. The company's long-term prospects look interesting with a pipeline spr

In the latest trading session, Exact Sciences (EXAS) closed at $62.45, marking a +0.19% move from the previous day.

Love it or hate it, tech investing is back on the menu in 2023. As a result, Cathie Wood's back in the limelight.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.